Gene Expression Signatures Predictive of Bevacizumab/Erlotinib Therapeutic Benefit in Advanced Nonsquamous Non-Small Cell Lung Cancer Patients (SAKK 19/05 trial). (Q41001434)
Jump to navigation
Jump to search
scientific article published on 28 April 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Gene Expression Signatures Predictive of Bevacizumab/Erlotinib Therapeutic Benefit in Advanced Nonsquamous Non-Small Cell Lung Cancer Patients (SAKK 19/05 trial). |
scientific article published on 28 April 2015 |
Statements
1 reference
Gene Expression Signatures Predictive of Bevacizumab/Erlotinib Therapeutic Benefit in Advanced Nonsquamous Non-Small Cell Lung Cancer Patients (SAKK 19/05 trial). (English)
1 reference
Anca Franzini
Florent Baty
Ina I Macovei
Oliver Dürr
Cornelia Droege
Daniel Betticher
Bogdan D Grigoriu
28 April 2015
1 reference